Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Rajki

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
The Journal of Nursing Administration|January 1, 1983
Nursing quality assurance: a process, not a toolC H Smeltzer, B Feltman, K Rajki
Immunology|August 1, 1984
Influence of subclass-specific anti-idiotypic antibodies on the kinetics of the immune response to BCGH Daus, H J Hammer, K Rajki, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1985
Experimental autoimmune myasthenia gravis: can pretreatment with 125I-labeled receptor prevent functional damage at the neuromuscular junction?R K Sterz, G Biro, K Rajki, et al.
Zentralblatt Fur Bakteriologie, Mikrobiologie Und Hygiene. 1. Abt. Originale A, Medizinische Mikrobiologie, Infektionskrankheiten Und Parasitologie = International Journal of Microbiology and Hygiene. A, Medical Microbiology, Infectious|March 1, 1982
Analysis of the soluble cytoplasmic components of Mycobacteria and Nocardia by crossed immunoelectrofocusingK Rajki, W Brehmer, H J Hammer, et al.
Muscle & Nerve|May 1, 1986
Effector mechanisms in myasthenia gravis: end-plate function after passive transfer of IgG, Fab, and F(ab')2 hybrid moleculesR Sterz, R Hohlfeld, K Rajki, et al.
Biological Chemistry Hoppe-Seyler|August 1, 1987
Antigen-gelonin conjugates. Preparation and application in experimental myasthenia gravisS Brust, G Filipp, U Hofmann, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
The Journal of Nursing Administration|January 1, 1983
Nursing quality assurance: a process, not a toolC H Smeltzer, B Feltman, K Rajki
Immunology|August 1, 1984
Influence of subclass-specific anti-idiotypic antibodies on the kinetics of the immune response to BCGH Daus, H J Hammer, K Rajki, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1985
Experimental autoimmune myasthenia gravis: can pretreatment with 125I-labeled receptor prevent functional damage at the neuromuscular junction?R K Sterz, G Biro, K Rajki, et al.
Zentralblatt Fur Bakteriologie, Mikrobiologie Und Hygiene. 1. Abt. Originale A, Medizinische Mikrobiologie, Infektionskrankheiten Und Parasitologie = International Journal of Microbiology and Hygiene. A, Medical Microbiology, Infectious|March 1, 1982
Analysis of the soluble cytoplasmic components of Mycobacteria and Nocardia by crossed immunoelectrofocusingK Rajki, W Brehmer, H J Hammer, et al.
Muscle & Nerve|May 1, 1986
Effector mechanisms in myasthenia gravis: end-plate function after passive transfer of IgG, Fab, and F(ab')2 hybrid moleculesR Sterz, R Hohlfeld, K Rajki, et al.
Biological Chemistry Hoppe-Seyler|August 1, 1987
Antigen-gelonin conjugates. Preparation and application in experimental myasthenia gravisS Brust, G Filipp, U Hofmann, et al.
Pageof 1